AssetMark’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
GJL
AssetMark's CLB Position: Q3 2026 in Review
AssetMark reduced its Core Laboratories (CLB) stake by 90% in Q3 2026, selling an estimated $3.1K and leaving 30 shares worth $291. The position accounts for ﹤0.01% of the portfolio, ranked #3547.
AssetMark first reported a position in CLB in Q3 2015 and has held it in 27 quarters since. The position peaked at $86.7K in Q2 2025. 131 funds tracked by Wall St. Rank hold CLB as of Q3 2026.
- AssetMark held 30 shares of Core Laboratories worth $291 as of Q3 2026.
- AssetMark sold 268 Core Laboratories shares in Q3 2026, an estimated $3.1K.
- Core Laboratories made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #3547 holding.
- AssetMark first reported a position in Core Laboratories in Q3 2015 and has held it in 27 quarters since.
- AssetMark's Core Laboratories position peaked at $86.7K in Q2 2025.
- 131 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.